Literature DB >> 4028370

Outcome of the Fontan procedure in patients with tricuspid atresia.

D D Mair, M J Rice, D J Hagler, F J Puga, D C McGoon, G K Danielson.   

Abstract

Between 1973 and 1983, 90 patients with tricuspid atresia underwent the Fontan operation at the Mayo Clinic. Operative mortality was 12% overall and decreased to 7% during the second 5 year period. At postoperative follow-up of 65 patients (1 to 10 years, mean 4), 50 (86%) of 58 present survivors were in excellent condition. There had been seven late deaths. Catheterization 0.5 to 8 years (mean 2.7) postoperatively in 25 patients disclosed a mean right atrial pressure of 14 mm Hg (range 6 to 21) and a mean cardiac index at rest of 3.0 (range 1.8 to 4.2). Mean left ventricular end-diastolic pressure was 8.5 mm Hg postoperatively compared with 16.5 mm Hg preoperatively; the decrease was secondary to a decreased ventricular volume load (mean volume load index 10.2 preoperatively, 3.0 postoperatively). We recommend that patients with tricuspid atresia have the Fontan operation by age 6 years to protect myocardial function.

Entities:  

Mesh:

Year:  1985        PMID: 4028370

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

1.  [The prognosis of total cavo-pulmonary anastomosis in relation to age at surgery].

Authors:  G Buheitel; M Hofbeck; J von der Emde; H Singer
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

2.  Dysrhythmias after the modified Fontan procedure.

Authors:  S C Chen; S Nouri; D G Pennington
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

3.  Surgical palliation of cardiac malformations associated with right isomerism.

Authors:  T Kawai; Y Wada; T Enmoto; S Nakajima; K Nishiyama; K Kitaura; S Sato; T Oka
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 4.  Computational modeling of Fontan physiology: at the crossroads of pediatric cardiology and biomedical engineering.

Authors:  Timothy C Slesnick; Ajit P Yoganathan
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-05       Impact factor: 2.357

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.